Amedisys (AMED) Tops Q1 EPS by 6c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $91.16 +0.12%
EPS Growth %: +2.0%
Financial Fact:
Interest expense: -1.14M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +2.0%
Financial Fact:
Interest expense: -1.14M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.47, $0.06 better than the analyst estimate of $0.41. Revenue for the quarter came in at $370.46 million versus the consensus estimate of $370.3 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Universal Insurance (UVE) Tops Q1 EPS by 10c
- Kinsale Capital Group (KNSL) Tops Q1 EPS by 16c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
